Skip to main content
. 2022 Oct 14;17(4):553–564. doi: 10.1093/ecco-jcc/jjac155

Figure 4.

Figure 4.

[a] LEfSe plot showing predicted MetaCyc pathways exhibiting significant differences in abundance in control or IBD patients. Differential abundance is indicated by the linear discriminant analysis [LDA] effect size score. Green bars are control associated and red bars IBD associated. Only features with Kruskall–Wallis p < 0.001 are shown. [b] Relative abundance of selected pathways [Thiazole biosynthesis and Superpathway of glycolysis and TCA] in controls and IBD patients.